See more : Valeo Pharma Inc. (VPHIF) Income Statement Analysis – Financial Results
Complete financial analysis of Accor SA (ACCYY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Accor SA, a leading company in the Travel Lodging industry within the Consumer Cyclical sector.
You may be interested
- Vantage Knowledge Academy Limited (VKAL.BO) Income Statement Analysis – Financial Results
- SIMEC Atlantis Energy Limited (SAE.L) Income Statement Analysis – Financial Results
- IMINT Image Intelligence AB (publ.) (IMNTF) Income Statement Analysis – Financial Results
- EnBW Energie Baden-Württemberg AG (EBK.DE) Income Statement Analysis – Financial Results
- Oracle Corporation Japan (4716.T) Income Statement Analysis – Financial Results
Accor SA (ACCYY)
About Accor SA
Accor SA operates a chain of hotels. It operates through two segments, HotelServices, and Hotel Assets & Other. The company owns, operates, manages, and franchises hotels. It also provides digital services to independent hotel operators through D-edge platform; ResDiary, a flat-rate online table reservation system that is designed for restaurant owners; Gekko solutions, including digital hotel distribution and loyalty platforms for the travel industry and large companies; and concierge and customized services through John Paul, as well as hotel booking services; and other services in events, fine dining, and entertainment through Paris Society and Potel & Chabot platforms. In addition, the company offers distribution activities, such as private sales of hotel accommodation and luxury vacations through VeryChic platform; rental of private residences operated by onefinestay; and coworking spaces through Wojo and Mama Works. Further, it provides hotel management, procurement, cash management, IT, and advertising services, as well as various advisory services. As of December 31, 2021, the company operated 5,298 hotels with 777,714 rooms in 110 countries worldwide. The company was founded in 1967 and is headquartered in Issy-les-Moulineaux, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.06B | 4.22B | 2.20B | 1.62B | 4.05B | 3.61B | 1.94B | 1.60B | 5.58B | 5.45B | 5.54B | 5.65B | 6.10B | 5.95B | 6.97B | 7.74B | 8.03B | 7.53B | 7.56B | 7.07B | 6.77B | 7.07B | 7.22B |
| Cost of Revenue | 4.00B | 2.18B | 1.35B | 1.17B | 2.05B | 1.92B | 877.00M | 767.00M | 2.31B | 2.29B | 2.40B | 2.47B | 391.00M | 399.00M | 752.00M | 806.00M | 795.00M | 799.00M | 747.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.06B | 2.05B | 850.00M | 456.00M | 2.00B | 1.70B | 1.06B | 836.00M | 3.27B | 3.17B | 3.14B | 3.18B | 5.71B | 5.55B | 6.22B | 6.93B | 7.23B | 6.73B | 6.82B | 7.07B | 6.77B | 7.07B | 7.22B |
| Gross Profit Ratio | 20.95% | 48.41% | 38.57% | 28.13% | 49.47% | 46.95% | 54.72% | 52.15% | 58.59% | 58.07% | 56.65% | 56.29% | 93.59% | 93.29% | 89.21% | 89.59% | 90.09% | 89.39% | 90.12% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 365.00M | 372.00M | 380.00M | 0.00 | 0.00 | 389.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 1.32B | 789.00M | 807.00M | 1.12B | 859.00M | 478.00M | 44.00M | 227.00M | 0.00 | 0.00 | 0.00 | 365.00M | 372.00M | 380.00M | 3.69B | 3.83B | 389.00M | 3.75B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 280.00M | 1.60B | 1.08B | 1.12B | 1.47B | 33.00M | -5.00M | 78.00M | 2.64B | -93.00M | 2.00M | 2.65B | -19.00M | -35.00M | -3.00M | 12.00M | 267.00M | -27.00M | -107.00M | 662.00M | 51.00M | 755.00M | 95.00M |
| Operating Expenses | 280.00M | 1.60B | 1.08B | 1.12B | 1.47B | 1.15B | 571.00M | 447.00M | 2.64B | 2.53B | 2.62B | 2.65B | 5.18B | 5.10B | 5.71B | 5.99B | 6.26B | 5.92B | 6.10B | 6.41B | 6.17B | 6.32B | 6.39B |
| Cost & Expenses | 4.28B | 3.78B | 2.43B | 2.29B | 3.52B | 3.06B | 1.45B | 1.21B | 4.95B | 4.82B | 5.02B | 5.12B | 5.57B | 5.50B | 6.46B | 6.80B | 7.05B | 6.72B | 6.85B | 6.41B | 6.17B | 6.32B | 6.39B |
| Interest Income | 6.00M | 13.00M | 3.00M | 19.00M | 19.00M | 7.00M | 23.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 75.00M | 106.00M | 92.00M | 72.00M | 77.00M | 76.00M | 93.00M | 65.00M | 71.00M | 58.00M | 83.00M | 84.00M | 97.00M | 134.00M | 132.00M | 86.00M | 92.00M | 96.00M | 122.00M | 100.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 279.00M | 228.00M | 249.00M | 274.00M | 328.00M | 120.00M | 126.00M | 109.00M | 329.00M | 318.00M | 328.00M | 326.00M | 398.00M | 434.00M | 498.00M | 446.00M | 419.00M | 436.00M | 432.00M | 437.00M | 436.00M | 455.00M | 443.00M |
| EBITDA | 1.03B | 794.00M | 286.00M | -1.96B | 1.01B | 626.00M | 623.00M | 507.00M | 458.00M | 920.00M | 1.00B | 856.00M | 871.00M | 871.00M | 1.00B | 1.43B | 1.66B | 1.22B | 1.23B | 1.10B | 1.04B | 1.21B | 1.27B |
| EBITDA Ratio | 20.43% | 17.57% | -11.98% | -60.27% | 21.88% | 23.27% | 35.05% | 35.25% | 17.34% | 18.15% | 18.14% | 15.33% | 15.97% | 14.64% | 14.35% | 19.77% | 20.26% | 18.16% | 16.25% | 15.54% | 15.34% | 17.11% | 17.64% |
| Operating Income | 779.00M | 543.00M | -227.00M | -665.00M | 678.00M | 229.00M | 413.00M | 389.00M | 665.00M | 602.00M | 536.00M | 526.00M | 530.00M | 446.00M | -141.00M | 941.00M | 971.00M | 811.00M | 717.00M | 662.00M | 603.00M | 755.00M | 830.00M |
| Operating Income Ratio | 15.41% | 12.86% | -10.30% | -41.02% | 16.74% | 6.34% | 21.32% | 24.27% | 11.92% | 11.04% | 9.68% | 9.31% | 8.69% | 7.50% | -2.02% | 12.16% | 12.10% | 10.77% | 9.48% | 9.36% | 8.90% | 10.68% | 11.50% |
| Total Other Income/Expenses | -100.00M | -83.00M | -108.00M | -107.00M | -75.00M | -64.00M | -53.00M | -117.00M | 0.00 | 0.00 | -280.00M | -288.00M | -93.00M | -458.00M | -498.00M | -56.00M | 175.00M | -123.00M | -222.00M | -195.00M | -80.00M | -52.00M | -72.00M |
| Income Before Tax | 679.00M | 461.00M | -55.00M | -2.31B | 603.00M | 160.00M | 360.00M | 169.00M | 408.00M | 419.00M | 259.00M | 239.00M | 326.00M | -12.00M | -144.00M | 885.00M | 1.15B | 688.00M | 488.00M | 592.00M | 523.00M | 703.00M | 758.00M |
| Income Before Tax Ratio | 13.43% | 10.91% | -2.50% | -142.44% | 14.89% | 4.43% | 18.59% | 10.54% | 7.31% | 7.68% | 4.68% | 4.23% | 5.34% | -0.20% | -2.07% | 11.44% | 14.28% | 9.13% | 6.45% | 8.37% | 7.72% | 9.94% | 10.50% |
| Income Tax Expense | 39.00M | 76.00M | -69.00M | -62.00M | 138.00M | 119.00M | -51.00M | -4.00M | 136.00M | 175.00M | 121.00M | 143.00M | 274.00M | 392.00M | 121.00M | 272.00M | 234.00M | 258.00M | 124.00M | 158.00M | 163.00M | 234.00M | 246.00M |
| Net Income | 633.00M | 402.00M | 14.00M | -2.25B | 464.00M | 2.23B | 441.00M | 265.00M | 244.00M | 223.00M | 126.00M | -599.00M | 27.00M | 3.60B | -282.00M | 575.00M | 883.00M | 501.00M | 333.00M | 261.00M | 304.00M | 452.00M | 505.00M |
| Net Income Ratio | 12.52% | 9.52% | 0.64% | -138.62% | 11.46% | 61.86% | 22.77% | 16.53% | 4.37% | 4.09% | 2.28% | -10.60% | 0.44% | 60.52% | -4.05% | 7.43% | 11.00% | 6.65% | 4.40% | 3.69% | 4.49% | 6.39% | 7.00% |
| EPS | 1.99 | 1.40 | 0.05 | -8.57 | 1.55 | 1.55 | 0.28 | 0.18 | 0.18 | 0.19 | 0.11 | -0.53 | 0.02 | 3.19 | -0.25 | 0.52 | 0.78 | 0.45 | 0.31 | 0.23 | 0.27 | 0.44 | 0.48 |
| EPS Diluted | 2.18 | 1.40 | 0.05 | -8.57 | 1.55 | 1.55 | 0.28 | 0.18 | 0.18 | 0.19 | 0.11 | -0.53 | 0.02 | 3.17 | -0.25 | 0.52 | 0.76 | 0.43 | 0.30 | 0.23 | 0.27 | 0.43 | 0.48 |
| Weighted Avg Shares Out | 290.37M | 262.53M | 261.62M | 262.23M | 271.82M | 1.44B | 1.44B | 1.30B | 1.17B | 1.15B | 1.14B | 1.14B | 1.14B | 1.13B | 1.11B | 1.11B | 1.13B | 1.12B | 1.07B | 995.63M | 988.65M | 987.87M | 985.21M |
| Weighted Avg Shares Out (Dil) | 265.24M | 263.02M | 261.62M | 262.23M | 272.29M | 1.45B | 1.44B | 1.30B | 1.18B | 1.16B | 1.14B | 1.14B | 1.14B | 1.13B | 1.11B | 1.11B | 1.18B | 1.22B | 1.24B | 1.12B | 1.05B | 1.02B | 989.02M |
Investors eye shares of hotels, cruise lines as U.S. vaccinations pick up
Investors are watching next week's earnings reports from hotels, cruise lines and other businesses that have been hard hit by COVID-19 for indications of which companies could be the first to bounce back when the pandemic recedes.
Axon Capital's Singh sees vaccine boosting travel, entertainment stocks
Services company stocks, especially those linked to travel and leisure, have room to rocket higher next year as consumers venture out again after spending on goods but cutting back on services during the pandemic, hedge fund manager Dinakar Singh said.
Accor And Ennismore Join Forces To Create Global Lifestyle Hotel Giant
The hotel industry may be struggling in the wake of COVID-19, but a new deal by two major global operators shows there is still lots of life left in the sector. Upscale French hotel giant Accor SA announced on Tuesday (Nov. 24)...
Qantas and Accor Unveil Strategic Partnership to Give Customers Greater Rewards
SYDNEY, Nov. 19, 2020 /PRNewswire/ - Qantas and Accor have announced a close collaboration to launch a deeper partnership that will see mutual members of their loyalty programs be rewarded at every stage of their travel journey. Scheduled to launch...
Travel stocks rally after Moderna's vaccine progress lifts hopes for near-term reopening
Airline, hotel, and cruise stocks surged in early Monday trading as Moderna's encouraging vaccine trial results spurred fresh optimism for an end to the coronavirus pandemic. The biotech company announced Monday morning that its experimental coronavirus vaccine was 94.5% effective...
Airline, hotel, and travel stocks poised for Monday rally on Pfizer vaccine news
Everything's up in the air right now. Health experts have long warned us not to get too excited about vaccine trials before the full range of data can be examined, but investors in the travel industry are doing just that.
Insider View: When Will The Hotel Industry Recover?
The Covid-19 pandemic has wreaked havoc on the hotel industry. Thom Geshay, president of Davidson Hotels & Resorts, shares predictions of what it will take, and when, for a full recovery.
The world’s biggest hotel group? Shares in Accor and IHG rise on merger speculation
A merger of France’s Accor and its U.K. rival IHG would create a group with 1.6 million rooms.
Source: https://incomestatements.info
Category: Stock Reports